India's First mRNA Vaccine
  • Home
  • WHO WE ARE
    • GENNOVA BIO
    • OUR STRENGTHS
  • ABOUT GEMCOVAC
    • STORY OF mRNA VACCINES
    • TECHNICAL DETAILS
  • MEDIA
    • PRESS COVERAGE
  • CONTACT US
    • SALES
    • HEALTHCARE PROFESSIONALS
    • HOSPITAL/INSTITUTION
    • MEDIA AND PRESS
  • More
    • Home
    • WHO WE ARE
      • GENNOVA BIO
      • OUR STRENGTHS
    • ABOUT GEMCOVAC
      • STORY OF mRNA VACCINES
      • TECHNICAL DETAILS
    • MEDIA
      • PRESS COVERAGE
    • CONTACT US
      • SALES
      • HEALTHCARE PROFESSIONALS
      • HOSPITAL/INSTITUTION
      • MEDIA AND PRESS
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

India's First mRNA Vaccine

Signed in as:

filler@godaddy.com

  • Home
  • WHO WE ARE
    • GENNOVA BIO
    • OUR STRENGTHS
  • ABOUT GEMCOVAC
    • STORY OF mRNA VACCINES
    • TECHNICAL DETAILS
  • MEDIA
    • PRESS COVERAGE
  • CONTACT US
    • SALES
    • HEALTHCARE PROFESSIONALS
    • HOSPITAL/INSTITUTION
    • MEDIA AND PRESS

Account


  • My Account
  • Sign out


  • Sign In
  • My Account
https://i.vimeocdn.com/video/1115432997-6644ee55f947906578d2e904078ef78f23a3d2dfbe64ec65fea36233c8c0847b-d

GEMCOVAC®-OM

GEMCOVAC®-OMGEMCOVAC®-OMGEMCOVAC®-OM

Gennova’s Omicron mRNA booster, GEMCOVAC®- OM, which is stable at 2-8°C, 

has received the Emergency Use Authorization (EUA)

KNOW MORE ABOUT COVID BOOSTER

Features

India's First mRNA Vaccine

SYNTHETIC & STABLE AT 2-8˚C

India's First mRNA Vaccine

Developed to address the problems in the earlier approved mRNA vaccines.

RAPID DEVELOPMENT

SYNTHETIC & STABLE AT 2-8˚C

India's First mRNA Vaccine

The mRNA development platform has the potential to develop rapidly.

SYNTHETIC & STABLE AT 2-8˚C

SYNTHETIC & STABLE AT 2-8˚C

SYNTHETIC & STABLE AT 2-8˚C

GEMCOVAC® mRNA vaccine is stable at 2–8 °C and can be considered superior in terms of deployability in India and other developing nations (especially LMICs) compared to other approved mRNA vaccines.

GEMCOVAC®-OM

Gennova's Omicron Specific mRNA booster vaccine.

GEMCOVAC®-OM SmPC (pdf)Download
GEMCOVAC®-OM Fact Sheet (pdf)Download
GEMCOVAC®-OM Pack Insert (pdf)Download

GEMCOVAC®-19

Gennova's mRNA vaccine prototype for COVID-19

1. GEMCOVAC™-19 - SmPC (pdf)Download
2. GEMCOVAC™-19 - Fact Sheet (pdf)Download
3. GEMCOVAC™-19 - Package Insert (pdf)Download

Gennova Biopharmaceuticals Limited

 CIN – U24231PN2001PLC016253
Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C.,
Hinjawadi, Pune – 411057, Maharashtra, INDIA 


R&D Address:

BTS – 2 Building, Chrysalis Enclave, Block – 2, Plot -2,
TCG International Biotech Park,
Phase II, MIDC, Hinjawadi, Pune – 411 057,
Maharashtra – India


Manufacturing Address:

Block -1, Plot P1 & P2, ITBT Park, Phase II, MIDC, 

Hinjawadi, Pune – 411 057, Maharashtra, India.

Copyright © 2006 - 2025 Gennova Biopharmaceuticals Limited - All Rights Reserved.

  • Privacy Policy
  • Terms and Conditions

COVID-19 BOOSTER

Click here to know more about the COVID-19 booster

COVID BOOSTER

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept